Intellia Therapeutics (NTLA) Return on Capital Employed Growth (1y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 68,255.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 2,665.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 31,429.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 2,503.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -105.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 2,400.00 |
| 10 | Intellia Therapeutics | 1.63 Bn | 1.63 Bn | - | -267.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -267.00 |
| Dec 31, 2025 | -668.00 |
| Sep 30, 2025 | -856.00 |
| Jun 30, 2025 | -1,368.00 |
| Mar 31, 2025 | -1,168.00 |
| Dec 31, 2024 | -533.00 |
| Sep 30, 2024 | -919.00 |
| Jun 30, 2024 | -1,058.00 |
| Mar 31, 2024 | -1,257.00 |
| Dec 31, 2023 | -557.00 |
| Sep 30, 2023 | 359.00 |
| Jun 30, 2023 | 205.00 |
| Mar 31, 2023 | 139.00 |
| Dec 31, 2022 | -1,644.00 |
| Sep 30, 2022 | -1,898.00 |
| Jun 30, 2022 | -828.00 |
| Mar 31, 2022 | -899.00 |
| Dec 31, 2021 | 461.00 |
| Sep 30, 2021 | 423.00 |
| Jun 30, 2021 | 530.00 |
| Mar 31, 2021 | 1,639.00 |
| Dec 31, 2020 | 775.00 |
| Sep 30, 2020 | 160.00 |
| Jun 30, 2020 | -425.00 |
| Mar 31, 2020 | -989.00 |
| Dec 31, 2019 | -396.00 |
| Sep 30, 2019 | -6.00 |
| Jun 30, 2019 | -432.00 |
| Mar 31, 2019 | -700.00 |
| Dec 31, 2018 | -622.00 |
| Sep 30, 2018 | -707.00 |
| Jun 30, 2018 | -737.00 |
| Mar 31, 2018 | -855.00 |
| Dec 31, 2017 | -1,279.00 |
| Sep 30, 2017 | -1,460.00 |
| Jun 30, 2017 | -624.00 |
| Mar 31, 2017 | 1,332.00 |